Published in Prog Clin Biol Res on January 01, 1985
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 14.15
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (1985) 9.94
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature (1988) 5.50
Monoclonal cytolytic T-cell lines. J Exp Med (1979) 5.28
Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med (1979) 5.22
Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med (1980) 4.32
Interleukin-2 augments natural killer cell activity. Nature (1981) 4.15
Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med (1978) 3.80
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science (1992) 3.64
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol (1979) 3.32
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol (1980) 3.28
T-cell growth factor-mediated T-cell proliferation. Ann N Y Acad Sci (1979) 3.16
The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med (1979) 3.15
In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. J Exp Med (1977) 3.11
Cloning, sequence and expression of human interleukin-2 receptor. Nature (1985) 3.02
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol (1983) 2.95
Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (1986) 2.84
The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem (1987) 2.78
Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. J Exp Med (1986) 2.71
The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature (1987) 2.68
Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol (1989) 2.64
IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. J Immunol (1989) 2.57
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem (1988) 2.46
Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A (1989) 2.46
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones. J Exp Med (1982) 2.14
Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest (1981) 2.04
Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol (1993) 2.02
Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol (1987) 2.00
Cloning, sequence and expression of bovine interleukin 1 alpha and interleukin 1 beta complementary DNAs. Mol Immunol (1988) 1.97
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
The effect of T cell growth factor on the generation of cytolytic T cells. J Immunol (1978) 1.92
Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor. J Biol Chem (1986) 1.90
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J Exp Med (1987) 1.85
Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 1.80
Interleukin 7 is a T-cell growth factor. Proc Natl Acad Sci U S A (1989) 1.79
Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. J Immunol (1980) 1.79
A rapid biologic assay for the detection of interleukin 1. J Immunol (1983) 1.77
Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J Exp Med (1982) 1.76
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72
Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol (1983) 1.72
Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem (1986) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line. Proc Natl Acad Sci U S A (1986) 1.70
Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol (1981) 1.70
Functional and molecular characteristics of T-cell growth factor. Mol Immunol (1980) 1.66
Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood (1996) 1.66
Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65
Glucocorticoids and immune responses. Arthritis Rheum (1979) 1.65
Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A (1985) 1.62
Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med (1992) 1.56
Failure of elevated heat shock protein 70 antibodies to alter cochlear function in mice. Hear Res (1998) 1.56
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol (1979) 1.53
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol (2000) 1.53
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Lymphokine purification by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.51
Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene (1987) 1.50
A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol (1994) 1.48
Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.47
Interleukin-2 dependent culture of cytolytic T cell lines. Immunol Rev (1981) 1.46
Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes. J Immunol (1986) 1.46
In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones. Proc Natl Acad Sci U S A (1989) 1.45
The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. J Immunol (1981) 1.42
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem (1994) 1.41
Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40). Eur J Immunol (1988) 1.41
Beta transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med (1987) 1.39
Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line. Proc Natl Acad Sci U S A (1984) 1.37
The influence of S17 stromal cells and interleukin 7 on B cell development. Eur J Immunol (1990) 1.35
Localization of human mononuclear cell interleukin 1. J Immunol (1987) 1.33
Recombinant IL-3 induces histamine release from human basophils. J Immunol (1989) 1.31
Characterization of the cell surface receptor for a multi-lineage colony-stimulating factor (CSF-2 alpha). J Biol Chem (1986) 1.31
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A (1993) 1.30
Interleukin 2: biology and biochemistry. J Clin Immunol (1983) 1.30
IL-1 and IFN-gamma increase vascular permeability. Immunology (1988) 1.29
Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts. J Biol Chem (1988) 1.27
Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor. J Exp Med (1986) 1.27
Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science (1990) 1.25
Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta. Proc Natl Acad Sci U S A (1987) 1.20
Induction of IL 2 responsiveness in a murine IL 3-dependent cell line. J Immunol (1985) 1.20